Table 3.
Sensitivity and specificity of salivary IgG for detection of prior SARS-CoV-2 infection.
Antigen | Isotype | Threshold (AU/mL) | Sensitivity at < 2 weeks | Sensitivity at 2–4 weeks | Sensitivity at 4–8 weeks | Specificity |
---|---|---|---|---|---|---|
SARS-CoV-2 Spike | IgG | 0.963 | 40.7% (22.4–61.2%) | 95.8% (78.9–99.9%) | 92.6% (75.7–99.1%) | 92.4% (87.4–95.9%) |
SARS-CoV-2 N | IgG | 3.18 | 48.1% (28.7–68.1%) | 79.2% (57.8–92.9%) | 92.6% (75.7–99.1%) | 90.7% (85.3–94.6%) |
SARS-CoV-2 S1 RBD | IgG | 0.244 | 66.7% (46.0–83.5%) | 91.7% (73.0–99.0%) | 92.6% (75.7–99.1%) | 64.5% (56.9–71.7%) |
Point estimates and 95% confidence intervals (indicated in parentheses) were computed at pre-established thresholds.